BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6600976)

  • 1. Reactivity of mitogen-induced autorosette-forming cells to interleukin 2 (T-cell growth factor).
    Ichikawa Y; Daniels JC
    Cell Immunol; 1983 Feb; 76(1):105-12. PubMed ID: 6600976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of mitogen-induced autorosette-forming cells: correlation with T-cell subsets and with lymphocyte proliferative responses to mitogens.
    Ichikawa Y; Lavastida MT; Gonzalez EB; Daniels JC
    Cell Immunol; 1983 Mar; 76(2):351-60. PubMed ID: 6601521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sex hormones on human T cell activation by concanavalin A.
    Yron I; Langer A; Weinstein T; Sahar E; Lidor Y; Pardo Y; Katz I; Shohat L; Kalechman Y; Ovadia J
    Nat Immun Cell Growth Regul; 1991; 10(1):32-44. PubMed ID: 2057020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active rosette forming cells as a possible functional subpopulation of human peripheral T lymphocytes.
    Harada M; Ishino C; Mori T; Hattori K
    Jpn J Exp Med; 1977 Dec; 47(6):489-94. PubMed ID: 305494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of autorosette forming cells in antibody synthesis in vitro: suppressive activity of ARFC in humoral immune response.
    Khansari N; Petrini M; Ambrogi F; Goldschmidt-Clermont P; Fudenberg HH
    Immunobiology; 1984 Jan; 166(1):1-11. PubMed ID: 6232205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human autologous rosette-forming cells. IV. Functional role in T-cell activation.
    Nalet V; Fournier C
    Cell Immunol; 1985 Nov; 96(1):137-46. PubMed ID: 3939108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of autorosette-forming cells in T-cell lymphoma.
    Tamura K; Aratake Y; Endo Y; Ohtaki S
    Leuk Res; 1984; 8(2):275-83. PubMed ID: 6609283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of human autorosette forming cells by phorbol myristate acetate.
    Sakano T; Hyodo S; Kittaka E; Tanaka Y; Usui T
    Clin Exp Immunol; 1982 Sep; 49(3):665-9. PubMed ID: 7172500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self recognition by autologous mixed lymphocyte reaction-primed cells.
    Tomonari K; Wakisaka A; Aizawa M
    J Immunol; 1980 Oct; 125(4):1596-600. PubMed ID: 6447728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and activity of autorosette forming cells in Con-A activated PBL from women with hyperplasia or carcinoma of the endometrium--possible role of estrogens.
    Yron I; Kalechman Y; Langer A; Lidor I; Luria B; Luria H; Ovadia J; Pardo Y; Shohat L
    J Clin Lab Immunol; 1990 Nov; 33(3):135-43. PubMed ID: 1967003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity to autologous non-T-cells and suppressor function of human autologous rosettes.
    Uchida A; Micksche M
    Immunol Lett; 1981 Aug; 3(3):145-9. PubMed ID: 6456984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous rosette forming cells in patients with renal diseases.
    Kuramochi T; Ohnuki T; Inoue T; Ishida M
    Clin Exp Immunol; 1983 Dec; 54(3):765-70. PubMed ID: 6606516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concanavalin A induced suppressor cell activity and autorosette forming cells in chronic myeloid leukemia patients.
    Somasundaram R; Advani SH; Gangal SG
    Br J Cancer; 1983 Dec; 48(6):783-90. PubMed ID: 6228243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
    Duncan MR; George FW; Hadden JW
    J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of concanavalin A-induced human suppressor and helper T cells by the autologous erythrocyte rosette technique.
    Sakane T; Honda M; Taniguchi Y; Kotani H
    J Clin Invest; 1981 Aug; 68(2):447-53. PubMed ID: 6455445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human peripheral blood T lymphocytes bearing receptors for autologous erythrocytes and T lymphocytes lacking these receptors.
    Sakane T; Honda M; Taniguchi Y; Kotani H; Niwa Y
    J Clin Immunol; 1982 Jan; 2(1):20-9. PubMed ID: 6212591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
    Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
    J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of a human T cell subpopulation bearing receptors for autologous erythrocytes by concanavalin A.
    Fournier C; Charreire J
    J Immunol; 1978 Aug; 121(2):771-6. PubMed ID: 308081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine production in T-lymphocyte subsets defined by active E-rosette formation.
    Robbins DS; Belden EL; Hoffman PM; Fudenberg HH; Strelkauskas AJ
    Scand J Immunol; 1982 Jun; 15(6):563-6. PubMed ID: 6750769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.
    Palacios R
    J Immunol; 1982 Jan; 128(1):337-42. PubMed ID: 6459373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.